The flow cytometry annexin V/PI patterns of MESR-incubated cells are displayed in Figure 3A. In Figure 3B, the annexin V-positive expression (%) for MESR treatment of oral cancer Ca9-22 cells was dose-responsively increased (p < 0.001). The gene discussed is ANXA5; the disease is lip and oral cavity carcinoma.